Advertisements
Advertisements
Question
Consult the internet and find out how to make orally active protein pharmaceuticals. What is the major problem to be encountered?
Advertisements
Solution 1
Orally active protein pharmaceuticals contain biologically active materials such as peptides or proteins, antibodies, and polymeric beads. The body administers it orally through various formulations. It involves encapsulating protein or peptide in liposomes or formulations using penetration enhancers. People use these proteins or peptides as vaccines and for the treatment of various diseases. However, the oral administration of these peptides or proteins presents several related challenges. Once ingested, the stomach juices’ proteases denature these proteins. This will nullify their effect. Therefore, it is essential to protect the therapeutic protein from digestive enzymes when it is taken orally. We inject the proteins directly into the target site to meet this requirement.
Solution 2
Proteinaceous drugs cannot be taken orally because they can be degraded by the proteases of our alimentary canal. To counteract this problem or to make an orally active protein pharmaceutical, it must be coated with a film that is resistant to protein-degrading enzymes.
APPEARS IN
RELATED QUESTIONS
Why do children cured by enzyme-replacement therapy adenosine deaminase deficiency need periodic treatment?
State the role of C-peptide in human insulin.
Compare and contrast the advantages and disadvantages of the production of genetically modified crops.
Diagrammatically represent the experimental steps in cloning and expressing an human gene (say the gene for growth hormone) into a bacterium like E. coli?
Can you suggest a method to remove oil (hydrocarbon) from seeds based on your understanding of rDNA technology and the chemistry of oil?
Explain how insulin can be produced using recombinant DNA technology.
Give a schematic representation of the transformation of a pro-insulin into insulin.
Answer the following question.
Describe the roles of heat, primers, and the bacterium Thermus aquaticus in the process of PCR.
Vaccines that use components of a pathogenic organism rather than the whole organism are called ____________.
Mention the number of primers required in each cycle of PCR. Write the role of primers and DNA polymerase in PCR. Name the source organism of the DNA polymerase used in PCR.
What are recombinant vaccines? Explain the types.
Human insulin is being commercially produced forma transgenic species of ______.
A probe which is a molecule used to locale-specific sequences in a mixture of DNA or RNA Mole cubs could be ______.
Which is false about antibiotics?
Which of the following is not an application of PCR (Polymerase Chain Reaction)?
Now a days it is possible to detect the mutated gene causing cancer by allowing a radioactive probe to hybridize its complimentary DNA in a clone of cells, followed by its detection using autoradiography because ______
Can a disease be detected before its symptoms appear? Explain the principle involved.
Why is it that the line of treatment for a genetic disease is different from infectious diseases?
Define Antigen and Antibody. Name any two diagnostic kits based upon them.
How does a gene therapy involving direct modification of the cells, in order to achieve a therapeutic goal is used in the treatment of ADA deficiency? Explain.
A host cell must be made competent, before it is able to receive an rDNA. Justify.
Explain how recombinant human insulin was prepared in 1983 by Eli Lily an American company.
Eli Lilly's contribution for diabetic patients through r-DNA technology has been overwhelmingly accepted. Explain how?
- Assertion: PCR is a powerful technique to identify genetic disorders.
- Reason: PCR can detect mutations in low amounts of DNA.
Give a reason for the following:
Streptokinase is administered to the patients having myocardial infarction.
Choose the INCORRECT statement.
